• In this whitepaper Montaka identifies key features of enterprise technology businesses that make them highly resilient and durable investments in most economic conditions. Download here.

The simple realities of governing in a pandemic


The simple realities of governing in a pandemic

Five months into the pandemic and one thing has become clear: eradication of COVID-19 is not a viable option for most nations. Instead, most are pursuing various forms of containment strategies aimed at buying time until widespread vaccinations can enable the return of more normal times.

And containment itself is proving to be a real challenge. Even in places that had seemingly broken-the-back of the outbreak, such as Japan, Spain, Israel and here in Australia, recent flare-ups are proving to be frustratingly resilient.


subscribe for free
or sign in to access the article


Andrew Macken is the Chief Investment Officer of the Montaka funds and the Montgomery Global funds. He established MGIM in 2015 in partnership with Montgomery.

This post was contributed by a representative of Montgomery Investment Management Pty Limited (AFSL No. 354564). The principal purpose of this post is to provide factual information and not provide financial product advice. Additionally, the information provided is not intended to provide any recommendation or opinion about any financial product. Any commentary and statements of opinion however may contain general advice only that is prepared without taking into account your personal objectives, financial circumstances or needs. Because of this, before acting on any of the information provided, you should always consider its appropriateness in light of your personal objectives, financial circumstances and needs and should consider seeking independent advice from a financial advisor if necessary before making any decisions. This post specifically excludes personal advice.

Why every investor should read Roger’s book VALUE.ABLE


find out more



  1. So I guess this ushers a new era of money printing to finance government spending? By ‘bond buying’, central banks are effectively creating money out of thin air to fund these programs. How long can this go on without driving up inflation?

  2. “165 candidate vaccines in record time, with 27 vaccines already in human trials.” It does appear likely that a vaccine with at least some degree of efficacy will be available over the coming months.”

    Andrew, the number of trials indicates the amount of money being directed at this problem but it does not solve the problem of whether a vaccine is even technically possible. Flu vax only works against a minority of flu which are constantly changing and we still have no vaccine for HIV despite massive investment.

Post your comments